ADILAdial Pharmaceuticals Inc

$2.98
$0.00
(0.00%)
Today
Closed $2.98
$0.14
(4.70%)
After Hours
Updated: 07:55 PM EDT
Mkt Cap$6.39M
Vol853,568.00
News
all
press releases
ADIL Stock Eyes Best Day In Over 5 Years — Major Pipeline Overhaul And $64M Raise Fuel Rally
Adial on Thursday announced that it has bought privately held Azora Therapeutics.
Stocktwits
News Placeholder
More News
News Placeholder
Adial Pharmaceuticals Applies For FDA Priority Voucher Program For AD04
(RTTNews) - Adial Pharmaceuticals, Inc. (ADIL) on Monday said it has submitted its AD04 application for consideration under the U.S. Food and Drug Administration Commissioner's National Priority Voucher Pilot Program (CNPV...
Nasdaq News: Markets
News Placeholder
Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder
Adial backs H.R. 7091 targeting AUD in veterans, spotlighting harm reduction therapies and expanding research beyond abstinence-based care.read more...
Benzinga
News Placeholder
Why Did Adial Pharmaceuticals Stock Plunge Over 20% After Hours Today?
The reverse split is intended to bring the company back into compliance with Nasdaq’s $1 minimum bid price rule.
Stocktwits
News Placeholder
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?
Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.
Zacks
News Placeholder
All You Need to Know About Adial Pharmaceuticals (ADIL) Rating Upgrade to Buy
Adial Pharmaceuticals (ADIL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
News Placeholder
Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's Why
Adial Pharmaceuticals (ADIL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
News Placeholder
Retail Traders Flock To Adial Pharma After Patent News Sends Shares Soaring
Adial Pharmaceuticals jumped to its highest level since February after receiving a U.S. patent for its precision medicine approach to treating addiction. The patent supports the use of AD04 in patients with specific genetic markers.
Stocktwits
<
...
1
>

Advertisement|Remove ads.